M
$ Value
$0
Shares
20,000
Price
$0
Filed
Sep 3
Insider
Name
Schmidt David
Title
—
CIK
0001594029
Roles
Director
Transaction Details
Transaction Date
2025-09-02
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
These shares were repurchased by the Issuer. | Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders. | These stock options were fully vested and exercisable.
Filing Info
Schmidt David's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-13 | ASTH | M | $116K |
| 2026-01-13 | ASTH | F | $116K |
| 2026-01-13 | ASTH | M | $0 |
| 2025-09-02 | ASTH | M | $364K |
| 2025-09-02 | ASTH | D | $555K |
| 2025-09-02 | ASTH | M | $0 |
| 2025-06-11 | ASTH | A | $0 |
Other Insiders at ASTH (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Lam Thomas S. | — | — | 2026-04-06 |
|
Sim Kenneth T.
Executive Chairman
|
— | — | 2026-04-06 |
|
Sim Brandon
CEO and President
|
— | — | 2026-04-06 |
|
Kumar Dinesh M.
Chief Medical Officer
|
— | — | 2026-04-01 |
|
Sobotka Glenn
Chief Accounting Officer
|
— | — | 2026-03-26 |
|
Basho Chandan
COO and CFO
|
— | — | 2026-04-14 |